Microbe inactivation processing device and cell activation processing device
Disclosed are a microbe inactivation processing device that can perform inactivation processing of microbes, while damage to human body cells is prevented or inhibited, with an efficient use of light emitted from a light source and the obtainment of a large effective irradiation area. Also provided are a cell activation processing device that can reliably activate target cells with high efficiency. The microbe inactivation processing device includes: a light source configured to emit light having a wavelength within a wavelength range of 190 nm to 237 nm; a power supply unit configured to supply electric power to the light source; a control unit configured to control the power supply unit; and an optical filter. The microbe inactivation processing device is configured to perform inactivation processing of a target microbe by applying the light emitted from the light source through the optical filter. When the light emitted from the light source is incident at an incident angle of 0°, the optical filter transmits at least a part of ultraviolet light having a wavelength within a range of not lower than 190 nm and not more than 230 nm, and transmits at least a part of ultraviolet light having a wavelength within a range of more than 230 nm and not more than 237 nm, and the optical filter blocks transmission of ultraviolet light having a wavelength out of a wavelength range of not lower than 190 nm and not more than 237 nm.
1. A microbe inactivation processing device comprising:
a light source being a KrCl lamp that is configured to emit light having a wavelength within a wavelength range of 190 nm to 237 nm;
a power supply unit configured to supply electric power to the light source;
a control unit configured to control the power supply unit; and
an optical filter having a dielectric multilayer film, the dielectric multilayer film including an HfO 2 layer and an SiO 2 layer, wherein
the microbe inactivation processing device is configured to perform inactivation processing of a target microbe by applying the light emitted from the light source through the optical filter,
when the light emitted from the light source is incident on the optical filter at an incident angle of 0°, the optical filter transmits at least a part of ultraviolet light having a wavelength within a range of not lower than 190 nm and not more than 230 nm, and transmits at least a part of ultraviolet light having a wavelength within a range of more than 230 nm and not more than 237 nm, the optical filter blocks transmission of ultraviolet light having a wavelength within wavelength ranges of UV-B and UV-C excluding a wavelength range of not lower than 190 nm and not more than 237 nm, and the optical filter has a transmittance of 80% or more with respect to ultraviolet light having a wavelength in the vicinity of 222 nm, and
the control unit controls a dose of light in the wavelength range of more than 230 nm to 237 nm to be applied to exposed human skin in a range from 150 mJ/cm 2 to 300 mJ/cm 2 .
2. A cell activation processing device comprising:
a first light source unit having a first light source, the first light source including a KrCl excimer lamp and configured to emit light having a wavelength within a wavelength range of 190 nm to 237 nm, and the first light source including an optical filter having a dielectric multilayer film, the dielectric multilayer film including an HfO 2 layer and an SiO 2 layer, the first light source unit being configured to emit the light from the first light source through the optical filter;
a first power supply unit configured to supply electric power to the first light source;
a second light source unit having a second light source configured to emit light having a wavelength in an infrared region;
a second power supply unit configured to supply electric power to the second light source; and
a control unit configured to control the first power supply unit and the second power supply unit, wherein
the cell activation processing device is configured to activate cells in a light irradiation area by applying light from the first light source and the second light source,
when the light emitted from the first light source is incident on the optical filter at an incident angle of 0°, the optical filter transmits at least a part of ultraviolet light having a wavelength within a range of not lower than 190 nm and not more than 230 nm, and transmits at least a part of ultraviolet light having a wavelength within a range of more than 230 nm and not more than 237 nm, and the optical filter blocks transmission of ultraviolet light having a wavelength within wavelength ranges of UV-B and UV-C excluding a wavelength range of not lower than 190 nm and not more than 237 nm, and the optical filter has a transmittance of 80% or more with respect to ultraviolet light having a wavelength in the vicinity of 222 nm, and
the control unit controls a dose of light in the wavelength range of more than 230 nm to 237 nm to be applied to exposed human skin in a range from 150 mJ/cm 2 to 300 mJ/cm 2 .
3. A microbe inactivation processing device comprising:
a light source being a KrCl excimer lamp that is configured to emit light having a wavelength within a wavelength range of 190 nm to 237 nm;
a power supply unit configured to supply electric power to the light source;
a control unit configured to control the power supply unit; and
an optical filter having a dielectric multilayer film, the dielectric multilayer film including an HfO 2 layer and an SiO 2 layer, wherein
the microbe inactivation processing device is configured to perform the inactivation processing on the target microbe present in a human body by applying the light emitted from the light source through the optical filter, and
when the light emitted from the light source is incident on the optical filter at an incident angle of 0°, the optical filter transmits at least a part of ultraviolet light having a wavelength within a range of not lower than 190 nm and not more than 230 nm, and transmits at least a part of ultraviolet light having a wavelength within a range of more than 230 nm and not more than 237 nm, the optical filter blocks transmission of ultraviolet light having a wavelength outside of a wavelength range of not lower than 190 nm and not more than 237 nm, and the optical filter has a transmittance of 80% or more with respect to ultraviolet light having a wavelength in the vicinity of 222 nm, and
the control unit controls a dose of light in the wavelength range of 190 nm to 237 nm, to be applied to the target microbe, at 300 mJ/cm 2 to 1000 mJ/cm 2 .
4. The microbe inactivation processing device according to claim 3 , wherein
the HfO 2 layer has a total thickness of less than 500 nm.
5. The microbe inactivation processing device according to claim 3 , configured to perform the inactivation processing on the target microbe present on a human body, and wherein
the control unit controls a dose of light in the wavelength range of 190 nm to 237 nm, to be applied to the target microbe, at 10 mJ/cm 2 to 1000 mJ/cm 2 .
6. A cell activation processing device comprising:
a first light source unit having a first light source, the first light source including a KrCl excimer lamp and configured to emit light having a wavelength within a wavelength range of 190 nm to 237 nm, and the first light source including an optical filter having a dielectric multilayer film, the dielectric multilayer film including an HfO 2 layer and an SiO 2 layer, the first light source unit being configured to emit the light from the first light source through the optical filter;
a first power supply unit configured to supply electric power to the first light source;
a second light source unit having a second light source configured to emit light having a wavelength in an infrared region;
a second power supply unit configured to supply electric power to the second light source; and
a control unit configured to control the first power supply unit and the second power supply unit, wherein
the cell activation processing device is configured to perform configured to perform cell activation processing of cells in a light irradiation area by applying light from the first light source and the second light source to the inside of a human body, and
when the light emitted from the first light source is incident on the optical filter at an incident angle of 0°, the optical filter transmits at least a part of ultraviolet light having a wavelength within a range of not lower than 190 nm and not more than 230 nm, and transmits at least a part of ultraviolet light having a wavelength within a range of more than 230 nm and not more than 237 nm, the optical filter blocks transmission of ultraviolet light having a wavelength outside of a wavelength range of not lower than 190 nm and not more than 237 nm, and the optical filter has a transmittance of 80% or more with respect to ultraviolet light having a wavelength in the vicinity of 222 nm, and
the control unit controls a dose of light in the wavelength range of 190 nm to 237 nm, to be applied by the first light source unit to the inside of the human body, at 300 mJ/cm 2 to 1000 mJ/cm 2 .
7. The cell activation processing device according to claim 6 , configured to perform cell activation processing by applying light to a surface of a human body, and wherein
the control unit controls a dose of light in the wavelength range of 190 nm to 237 nm, to be applied by the first light source unit to the surface of the human body, at 10 mJ/cm 2 to 1000 mJ/cm 2 .
8. The cell activation processing device according to claim 6 , wherein
the control unit controls the first power supply unit to turn on the first light source, and after a predetermined time has elapsed since the first light source was turned on, the control unit controls the second power supply unit to turn on the second light source.